Fulgent Genetics Inc (FLGT) support and resistance · rev $156.5M
Fulgent Genetics Inc (FLGT) is a diagnostics & research company listed on US.
This page maps Fulgent Genetics Inc (FLGT) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported FLGT revenue for 2026-06-30 was $156.5M. Net income was -$54.4M. FLGT currently screens at market cap $586.6M.
FLGT currently screens at market cap $586.6M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new FLGT 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the FLGT quote page for the session range and the stock page for the full model.
Not investment advice.